Institutional Cluster

ACAD

ACADIA PHARMACEUTICALS INC
BEARISH
Impact 6/10
Horizonweeks Processed3mo ago
Institutional cluster: 2 buyers, 5 sellers (bearish)
Actionable Insight ▼ Bearish

The coordinated selling by multiple large holders suggests a shared negative thesis. Monitor for upcoming catalyst (e.g., pipeline data, regulatory decision) that may have precipitated this flight. The stock could face further pressure if additional institutional sales follow.

DirectionBearish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
ACAD ▲ +31.00% at T+60d
SHORT call ✗ call lost -31.00% · α vs SPY -26.60% · entry $21.39 → $28.02
Entry anchored
Jun 11, 10:36 AM ET
via exchange tick
T+1d
-1.40%
call +1.40% · α +1.94%
$21.09
settled 4mo ago
T+5d
+0.98%
call -0.98% · α -0.55%
$21.60
settled 4mo ago
T+20d
+23.47%
call -23.47% · α -21.58%
$26.41
settled 3mo ago
T+60d
+31.00%
call -31.00% · α -26.60%
$28.02
settled 24d ago

Executive Summary

A bearish institutional cluster emerged in ACAD during Q3 2025: 5 major sellers reduced holdings by ~$192.7M while only 2 buyers added $14.3M. Notable full exits from Norges Bank and near-exits from Citadel and Point72 suggest broad-based negative sentiment.

Key Financial Metrics

Direction
distributing
Buy Value
$28.4M
Sell Value
$192.7M
Net Flow
-$164.3M

Institutional Positions

Net institutional flow: -$164.3M

▲ Buyers (2)

InstitutionActionChangePosition ValueValue Δ
FidelityDOUBLED+293.1%$14.2M$10.6M
Two SigmaADD+37.8%$14.2M$3.8M

▼ Sellers (5)

InstitutionActionChangePrev ValueValue Δ
Norges BankEXIT-100%$31.7M-$31.7M
Morgan StanleyTRIM-71.1%$88.7M-$63.3M
CitadelNEAR_EXIT-89.3%$65.0M-$58.1M
Point72TRIM-53.1%$68.4M-$36.7M
Ubs Am, A Distinct Business UnTRIM-38.4%$7.4M-$2.9M

Key Facts

  • Net institutional selling of ~$192.7M vs buying of $14.3M
  • Norges Bank fully exited a $31.7M position
  • Morgan Stanley cut 71.1% of its stake ($63.3M sold)
  • Citadel reduced 89.3% ($58.1M sold), Point72 trimmed 53.1% ($36.7M sold)
  • Fidelity doubled its position to $14.2M, Two Sigma added 37.8% to $14.2M

Financial Impact

2 buyers adding $14.3M vs 5 sellers offloading $192.7M, net institutional outflow of ~$178.3M

institutional ownershipfloat

Risk Factors

  • Continued institutional selling pressure
  • Potential negative fundamental catalyst (e.g., trial failure, regulatory setback)
  • Low historical win rate (33%) on prior ACAD calls limits predictive confidence

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
78% bullish (27 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-ACAD-2025-Q3
9 reports for ACAD
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ACAD — sortable, filterable
TypeNow
Sep 11, 2026
20d ago
8-K
NEUTRAL ★ 3/10
$27.52 $26.40▼ −4.09%▼ −4.19%—
Aug 17, 2026
6w ago
Institutional Cluster
MIXED ★ 5/10
$29.01 $29.65▲ +2.21%▲ +3.40%—
Aug 7, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$29.39 $29.01▼ −1.29%▼ −1.25%—
Jun 11, 2026
16w ago
Institutional Cluster
BEARISH ★ 6/10
$21.39 $21.60▼ −0.98%▼ −0.55%—
May 6, 2026
21w ago
8-K
BEARISH ★ 6/10
$22.56 $22.18▲ +1.68%▲ +3.19%—
May 4, 2026
21w ago
Insider Cluster
NEUTRAL ★ 2/10
$22.19 $21.80▼ −1.76%▼ −4.69%—
Mar 25, 2026
27w ago
Insider Cluster
NEUTRAL ★ 4/10
$22.01 $22.32▲ +1.41%▲ +1.65%—
Mar 5, 2026
30w ago
8-K
NEUTRAL ★ 3/10
$22.40 $21.27▼ −5.04%▼ −2.81%—
Feb 25, 2026
31w ago
8-K
BULLISH ★ 8/10
$24.64 $22.40▼ −9.09%▼ −7.96%—
Showing 9 of 9

US Market Status

Market Closed — Opens Mon (65h 28m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 11, 2026